Fidelity Investments’s Olema Pharmaceuticals OLMA Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $120K | Buy |
28,241
+26,426
| +1,456% | +$113K | ﹤0.01% | 3529 |
|
2025
Q1 | $6.82K | Sell |
1,815
-44,013
| -96% | -$165K | ﹤0.01% | 4609 |
|
2024
Q4 | $267K | Buy |
45,828
+43,927
| +2,311% | +$256K | ﹤0.01% | 3158 |
|
2024
Q3 | $22.7K | Buy |
1,901
+865
| +83% | +$10.3K | ﹤0.01% | 4116 |
|
2024
Q2 | $11.2K | Buy |
1,036
+40
| +4% | +$433 | ﹤0.01% | 4290 |
|
2024
Q1 | $11.3K | Buy |
996
+88
| +10% | +$996 | ﹤0.01% | 4227 |
|
2023
Q4 | $12.7K | Sell |
908
-728
| -44% | -$10.2K | ﹤0.01% | 4158 |
|
2023
Q3 | $20.2K | Buy |
1,636
+972
| +146% | +$12K | ﹤0.01% | 3796 |
|
2023
Q2 | $6K | Sell |
664
-8
| -1% | -$72 | ﹤0.01% | 4309 |
|
2023
Q1 | $2.33K | Sell |
672
-24
| -3% | -$83 | ﹤0.01% | 4590 |
|
2022
Q4 | $1.71K | Buy |
696
+342
| +97% | +$838 | ﹤0.01% | 4551 |
|
2022
Q3 | $1K | Sell |
354
-3,579
| -91% | -$10.1K | ﹤0.01% | 4717 |
|
2022
Q2 | $16K | Sell |
3,933
-104,712
| -96% | -$426K | ﹤0.01% | 3962 |
|
2022
Q1 | $463K | Sell |
108,645
-454,209
| -81% | -$1.94M | ﹤0.01% | 3010 |
|
2021
Q4 | $5.27M | Sell |
562,854
-44,197
| -7% | -$414K | ﹤0.01% | 2351 |
|
2021
Q3 | $16.7M | Sell |
607,051
-35,700
| -6% | -$984K | ﹤0.01% | 1924 |
|
2021
Q2 | $18M | Sell |
642,751
-9,946
| -2% | -$278K | ﹤0.01% | 1886 |
|
2021
Q1 | $21.7M | Sell |
652,697
-1,800
| -0.3% | -$59.7K | ﹤0.01% | 1772 |
|
2020
Q4 | $31.5M | Buy |
+654,497
| New | +$31.5M | ﹤0.01% | 1509 |
|